Comparisons of oseltamivir-resistant (H275Y) and concurrent oseltamivir-susceptible seasonal influenza A(H1N1) virus infections in hospitalized adults, 2008–2009
Version of Record online: 14 JUN 2012
© 2012 Blackwell Publishing Ltd
Influenza and Other Respiratory Viruses
Volume 7, Issue 3, pages 235–239, May 2013
How to Cite
Chan, M. C. W., Lee, N., Lui, G. C. Y., Ngai, K. K. L., Wong, R. Y. K., Choi, K.-W. and Chan, P. K. S. (2013), Comparisons of oseltamivir-resistant (H275Y) and concurrent oseltamivir-susceptible seasonal influenza A(H1N1) virus infections in hospitalized adults, 2008–2009. Influenza and Other Respiratory Viruses, 7: 235–239. doi: 10.1111/j.1750-2659.2012.00387.x
- Issue online: 17 APR 2013
- Version of Record online: 14 JUN 2012
- Accepted 30 April 2012. Published online 4 June 2012.
- seasonal influenza A(H1N1) virus
In an observational cohort study, we found that adults hospitalized for oseltamivir-resistant (H275Y) seasonal H1N1 influenza (n = 46) were older than those infected with oseltamivir-susceptible strains (n = 31) [74(IQR 59–83) versus 64(IQR 48–76) years; P = 0·045], and most had major comorbidities (78% versus 65%). Disease severity and clinical outcomes were comparable between the two groups: radiographic pneumonia 40–42%, supplemental oxygen use 47–48%, critical illness 11–13%, median duration of hospitalization 5–6 days, death rate 6–9%. Failure to receive effective antiviral therapy was associated with progression to critical illness (23% versus 0%, P = 0·016) and death (20% versus 0%, P = 0·033) in hospitalized patients with seasonal H1N1 influenza.